Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells. (Q50936345)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Aysel Yurtsever

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ayfer Haydaroglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Cigir Biray Avci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Cumhur Gunduz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nezih Oktar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tayfun Dalbasti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hasan Onur Caglar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Gul Kitapcioglu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

5 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

105-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Biologic principles of immunotherapy for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Epigenetic modifications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Challenges in clinical design of immunotherapy trials for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

CD133 is essential for glioblastoma stem cell maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Isolation and characterization of cancer stem like cells in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Cytokine-based log-scale expansion of functional murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

The bidirectional crosstalk between human dendritic cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

The role of CD45 and CD45-associated molecules in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-013-0065-8

NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion

21 January 2018

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

12 December 2020

Cellular-based immunotherapies for patients with glioblastoma multiforme.

1 reference

12 December 2020

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

1 reference

12 December 2020

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.

1 reference

12 December 2020

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

12 December 2020

10.1007/S13577-013-0065-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json

release_zg62skov5jfyzne7yxiee4b27q

2 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zg62skov5jfyzne7yxiee4b27q

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737374%20AND%20SRC:MED&resulttype=core&format=json